MarketCrunch AI combines news sentiment, technical indicators, insider activity and analyst ratings to generate a 24-hour price forecast with confidence scoring for Inhibikase Therapeutics, Inc. (IKT).
IKT — Inhibikase Therapeutics, Inc.: $1.74 (+3.57% today).
Run a live AI forecast to see the top bullish signals driving IKT.
Run a live AI forecast to see the top bearish signals affecting IKT.
Every forecast fuses four independent signal streams through an ensemble model trained on years of market data.
Real-time NLP scoring of thousands of news articles and social signals for IKT.
RSI, MACD, Bollinger Bands and 20+ momentum indicators for IKT processed daily.
SEC Form 4 filings tracked and weighted to surface meaningful insider moves in Inhibikase Therapeutics, Inc..
Wall Street consensus and revision trends for IKT incorporated into the model.
Run a live forecast on MarketCrunch AI to get the latest price target for Inhibikase Therapeutics, Inc. (IKT).
MarketCrunch AI continuously evaluates model accuracy. Run a live forecast to see the latest accuracy for IKT.
The IKT forecast is generated by combining four independent signal streams: real-time news sentiment analysis, technical indicators (RSI, MACD, Bollinger Bands and 20+ more), insider activity from SEC Form 4 filings, and Wall Street analyst ratings and revision trends.
MarketCrunch AI generates a fresh 24-hour forecast for Inhibikase Therapeutics, Inc. (IKT) each time you run an analysis. The model processes real-time data, so every forecast reflects the latest available information.
Get AI forecasts for other popular stocks:
© 2026 MarketCrunch AI. This is not financial advice. Past performance does not guarantee future results. Always do your own research before investing.